Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Sales (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Sales over the past 16 years, most recently at 0.0% for Q1 2025.

  • Quarterly results put Return on Sales at 0.0% for Q1 2025, down 2.0% from a year ago — trailing twelve months through Feb 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2024 was 0.02%, up 36.0%.
  • Return on Sales for Q1 2025 was 0.0% at Lifecore Biomedical, Inc. \De\, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for LFCR hit a ceiling of 0.08% in Q3 2023 and a floor of 1.84% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.05% (2021), compared with a mean of 0.31%.
  • Biggest five-year swings in Return on Sales: plummeted -179bps in 2022 and later soared 176bps in 2023.
  • Lifecore Biomedical, Inc. \De\'s Return on Sales stood at 1.8% in 2021, then skyrocketed by 91bps to 0.16% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then skyrocketed by 916bps to 0.01% in 2024, then crashed by -100bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q1 2025), 0.01% (Q4 2024), and 0.01% (Q3 2024) per Business Quant data.